Targets: VEGFR
Apatinib was first synthesized by Advenchen Laboratories in California, USA and is being developed by Jiangsu Hengrui Medicine (China), LSK BioPartners (US) and Bukwang Pharmaceutical Company (Korea)
Synthesis os apatinib
US7129252
"Six membered amino-amide derivatives an angiogenisis inhibitors"
28 february 2013
Комментариев нет:
Отправить комментарий